Chronic myeloid leukemia in accelerated phase: Treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patients

European Journal of Haematology

Volumn 61, Issue 1, 1998, Pages 7-13

  Griesshammer, M ^a,d   Arnold, R ^b   Bangerter, M ^a   Hafner, M ^a   Heinze, B ^a   Hertenstein, B ^c   Heimpel, H ^a   Bunjes, D ^a  

^a UNIVERSITY OF ULM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Department of Internal Medicine III   (Germany)

Author keywords

Accelerated phase disease; Bone marrow transplantation; Chronic myeloid leukemia; Conventional chemotherapy

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HYDROXYUREA; INTERFERON;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS HOST REACTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORGAN DONOR; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0031866457     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01054.x     Document Type: Article

References (27)

1. KANTARJIAN HM, DEISSEROTH A, KURZROCK R, ESTROV Z, TALPAZ M. Chronic myelogenous leukemia. A concise update. Blood 1993: 82: 691-703.
2. GRIESSHAMMER M, HEINZE B, HELLMANN A, et al. Chronic myclogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients. Ann Hematol 1996: 73: 225-230.
3. KANTARJIAN HM, DIXON D, KEATING MJ, et al. Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer 1988: 61: 1441-1446.
4. THOMAS ED, CLIFT RA, FEFER A, et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986: 61: 155-163.
5. GOLDMAN JM, APPERLEY JF, JONES L, et al. Bone marrow transplantation for patients with chronic myelogenous leukemia. New Engl J Med 1986: 314: 202-207.
6. ARMITAGE JO. Bone marrow transplantation. New Engl J Med 1994: 330: 827-838.
7. CHAMPLIN RE, GOLDMAN JM, GALE RP. Bone marrow transplantation in chronic myelogenous leukemia. Semin Hematol 1988: 25: 74-80.
8. THOMAS ED, CLIFT RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989: 73: 861-864.
9. MCGLAVE PB. Therapy of chronic myelogenous leukemia with bone marrow transplantation. In: CHAMPLIN R, ed. Bone Marrow Transplantation. Kluwer Academic: Boston, MA: 1990: 235-258.
10. CLIFT RA, BUCKNER CD, THOMAS ED, et al. Marrow transplantation for patients in accelerated phase of chronic mycloid leukemia. Blood 1994: 84: 4368-4373.
11. MARTIN PJ, CLIFT RA, FISHER LD, et al. HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: Analysis of survival and remission duration. Blood 1988: 72: 1978-1984.
12. HEIT W, BUNJES D, WIESNETH M, et al. Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versushost disease in allogeneic bone marrow transplantation. Br J Haematol 1986: 64: 479-487.
13. THE ITALIAN COOPERATIVE GROUP ON CHRONIC MYELOID LEUKEMIA. Interferon alpha-2A as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New Engl J Med 1994: 330: 820-825.
14. HEHLMANN R, HEIMPEL H, HASFORD J, et al. Randomized comparison of Interferon with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 1994: 84: 4064-4077.
15. ALLAN NC, RICHARDS SM, SHEPARD PC. UK Medical Research Council randomized, multicentre trial of interferon-alpha n1 for chronic mycloid leukemia: improved survival irrespective of cytogenetic response. Lancet 1995: 345: 1392-1397.
16. McGLAVE P, ARTHUR D, HAAKE R, et al. Therapy of chronic myclogenous leukemia with allogeneic bone marrow transplantation. J Clin Oncol 1987: 5: 1033-1040.
17. BIGGS JC, SZER J, CRILLEY P, et al. Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2. Blood 1992: 80: 1352-1357.
18. KANTARJIAN HM, TALPAZ M. Definition of the accelerated phase of chronic myelogenous leukemia. J Clin Oncol 1988: 6: 180-181.
19. CERVANTES F, LOPEZ-GRUILLERMO A, BOSCH F, TEROL MJ, ROZMAN C, MONTSERRAT E. An assessment of the clinicohematological criteria for the accelerated phase of chronic myeloid leukemia. Eur J Hematol 1996: 57: 286-291.
20. KRULIK M, SMADJA N, DEGRAMONT A, et al. Sequential karyotype study on Ph-positive chronic myelocytic leukemia: significance of additional chromosomal abnormalities during disease evolution. Cancer 1987: 60: 974-979.
21. ANASTASI J, FENG J, LE-BEAU MM, LARSON RA, ROWLEY JD, VARDIMAN JW. The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. Leukemia 1995: 9: 628-633.
22. JEHN U, POTSCHER C, HEINEMANN V. Successful treatment of accelerated and blastic phase of chronic myeloid leukemia with high-dose interferon alpha and hydroxyurea: a novel approach. Leuk Lymph 1995: 19: 153-157.
23. THOMAS ED, CLIFT RA. Indications for marrow transplantation in chronic myelogenous leukemia. Blood 1989: 73: 861-864.
24. BISHOP MR, HENSLEE-DOWNEY PJ, ANDERSON JR, et al. Longterm survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors. Bone Marrow Transplant 1996: 18: 747-753.
25. SPEISER DE, HERMAMS J, VAN BIEZES A, et al. Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1997: 19: 1197-1203.
26. SZYDLO R, GOLDMAN JM, KLEIN JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997: 15: 1767-1777.
27. REIFFERS J, MONTASTRUC M, MARIT G, et al. Autologous blood stem cell transplantation followed by recombinant alpha interferon as treatment for patients with high-risk chronic myelogenous leukemia. A report of 32 cases. Leuk Lymph 1993: 11: 297-299.